Marisa Iborra

2.5k total citations
61 papers, 1.3k citations indexed

About

Marisa Iborra is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Marisa Iborra has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Genetics, 33 papers in Epidemiology and 21 papers in Immunology. Recurrent topics in Marisa Iborra's work include Inflammatory Bowel Disease (53 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (7 papers). Marisa Iborra is often cited by papers focused on Inflammatory Bowel Disease (53 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (7 papers). Marisa Iborra collaborates with scholars based in Spain, Italy and United States. Marisa Iborra's co-authors include Belén Beltrán, Pilar Nos, Inés Moret, Silvio Danese, Pietro Invernizzi, Francesca Bernuzzi, Guillermo Bastida, Elena Cerrillo, Esteban Sáez‐González and Mariam Aguas and has published in prestigious journals such as Gastroenterology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Marisa Iborra

60 papers receiving 1.3k citations

Peers

Marisa Iborra
Feihong Deng China
Sailish Honap United Kingdom
Jiaming Qian China
Wen Zhou China
Kousaku Kawashima Japan
Katarzyna Neubauer Poland
Steven M. Cohn United States
Daniela Vogl Germany
Simranjeet Kaur Denmark
Qiqing Huang China
Feihong Deng China
Marisa Iborra
Citations per year, relative to Marisa Iborra Marisa Iborra (= 1×) peers Feihong Deng

Countries citing papers authored by Marisa Iborra

Since Specialization
Citations

This map shows the geographic impact of Marisa Iborra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Iborra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Iborra more than expected).

Fields of papers citing papers by Marisa Iborra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisa Iborra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Iborra. The network helps show where Marisa Iborra may publish in the future.

Co-authorship network of co-authors of Marisa Iborra

This figure shows the co-authorship network connecting the top 25 collaborators of Marisa Iborra. A scholar is included among the top collaborators of Marisa Iborra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisa Iborra. Marisa Iborra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huguet, José María, Marisa Iborra, Lukas Marti, et al.. (2024). P657 Persistence of subcutaneous infliximab after two years of the switch from intravenous infliximab to subcutaneous infliximab in Inflammatory Bowel Disease patients. Journal of Crohn s and Colitis. 18(Supplement_1). i1242–i1242. 1 indexed citations
3.
Tran, Yvonne, Philip J Smith, Marisa Iborra, et al.. (2024). Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn s and Colitis. 18(9). 1440–1449. 9 indexed citations
4.
Iborra, Marisa, Berta Caballol, António Garrido, et al.. (2024). P516 Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes. Journal of Crohn s and Colitis. 18(Supplement_1). i1013–i1014. 2 indexed citations
5.
Sáez‐González, Esteban, Guillermo Bastida, Mariam Aguas, et al.. (2023). MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitis. Journal of Clinical Apheresis. 39(1). e22101–e22101. 3 indexed citations
6.
Masnou, Helena, Francisco Mesonero, Luís Menchén, et al.. (2023). Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review. Journal of Clinical Medicine. 12(23). 7366–7366. 3 indexed citations
7.
Iborra, Marisa, Guillermo Bastida, Mariam Aguas, et al.. (2022). P383 Ustekinumab as an opportunity for refractory Ulcerative Colitis patients. Journal of Crohn s and Colitis. 16(Supplement_1). i383–i384. 5 indexed citations
8.
9.
Sáez‐González, Esteban, Inés Moret, Marisa Iborra, et al.. (2021). Oxidative Stress in the Pathogenesis of Crohn’s Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants. 10(1). 64–64. 78 indexed citations
10.
Paredes, Ana García García de, Enrique Rodríguez de Santiago, Marisa Iborra, et al.. (2020). Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study. Pancreatology. 20(3). 331–337. 14 indexed citations
11.
Iborra, Marisa, et al.. (2019). Intestinal tuberculosis simulating Crohn's disease: Differential diagnosis. Gastroenterología y Hepatología (English Edition). 42(1). 29–32. 1 indexed citations
12.
Iborra, Marisa, Belén Beltrán, Nuria Maroto, et al.. (2018). Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. Gastroenterología y Hepatología (English Edition). 41(9). 535–543. 1 indexed citations
13.
Beltrán, Belén, Marisa Iborra, Esteban Sáez‐González, et al.. (2018). Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn’s Disease. Digestive Diseases. 37(2). 108–115. 34 indexed citations
14.
Frasson, Matteo, Elena Cerrillo, Belén Beltrán, et al.. (2017). Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease. Journal of Surgical Research. 213. 290–297. 12 indexed citations
15.
Bosó, Virginia, Belén Navarro, Guillermo Bastida, et al.. (2017). Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice. Inflammatory Bowel Diseases. 23(8). 1454–1460. 23 indexed citations
16.
Domènech, Eugeni, Marisa Iborra, Ana Gutiérrez, et al.. (2017). Incidence and Management of Recurrence in Patients with Crohnʼs Disease Who Have Undergone Intestinal Resection. Inflammatory Bowel Diseases. 23(10). 1840–1846. 17 indexed citations
17.
Iborra, Marisa, Belén Beltrán, & Pilar Nos. (2016). Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America. 26(4). 641–656. 14 indexed citations
18.
Cerrillo, Elena, et al.. (2015). Fecal Calprotectin in Ileal Crohnʼs Disease. Inflammatory Bowel Diseases. 21(7). 1572–1579. 54 indexed citations
19.
Moret, Inés, et al.. (2013). Estrés oxidativo en la enfermedad de Crohn. Gastroenterología y Hepatología. 37(1). 28–34. 13 indexed citations
20.
Iborra, Marisa, Belén Beltrán, Guillermo Bastida, Mariam Aguas, & Pilar Nos. (2010). Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect. Journal of Crohn s and Colitis. 5(2). 157–161. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feihong Deng Breakdown of academic impact, for papers by Sailish Honap Breakdown of academic impact, for papers by Jiaming Qian Breakdown of academic impact, for papers by Wen Zhou Breakdown of academic impact, for papers by Kousaku Kawashima Breakdown of academic impact, for papers by Katarzyna Neubauer Breakdown of academic impact, for papers by Steven M. Cohn Breakdown of academic impact, for papers by Daniela Vogl Breakdown of academic impact, for papers by Simranjeet Kaur Breakdown of academic impact, for papers by Qiqing Huang
Rankless by CCL
2026